Pet Health Stocks Surge 8%, Market Cap Increases by $15 Billion in a Day

Elanco Animal Health Inc. (ELAN) jumped 7.8% on the New York Stock Exchange, closing at $24.93. Trading volume topped 2.88 million shares, and the company’s market capitalization rose by about $1 billion—roughly KRW 1.5 trillion—in a single session, bringing its total to approximately $12.4 billion, or around KRW 18 trillion.

In its fourth-quarter 2025 earnings report released in February, Elanco exceeded market expectations, with revenue up more than 12% year-over-year and organic sales growth of 9%.

Recent analyst commentary on Wall Street—most notably from Stifel—has maintained buy ratings and target prices near $30, classifying Elanco as a “buy” based on consensus estimates.

Headquartered in Indiana, Elanco is a top-three global animal health company, specializing in vaccines and therapeutics for companion animals and livestock. Since spinning off from Eli Lilly, it has expanded its product portfolio through major acquisitions and increased R&D investment. The company has also restructured its holdings to reduce debt and improve profitability, including the 2024 divestiture of its aquaculture business to Merck.